Tier 3 — preclinical
Creatine monohydrate supplementation for recovery from muscle disuse: Timing matters
Sports Med Health Sci
2026
8(5):495-500
Bibliography
- PubMed
- PMID 42539704
- PubMed Central
- PMC13424173
- Funding
- No explicit funding statement was located in the accessible PubMed or publisher records during Biohack Blueprint's 2026-10-02 audit. This is an audit-status statement, not confirmation that the study received no funding.
- Competing interests
- Jeffrey R. Stout reported long-term dietary-supplement-industry funding and serves as an unpaid scientific advisor for AlzChem Inc.; Patrick S. Pabian declared no known competing financial interests or personal relationships.
Study snapshot
| Design | Narrative mini-review |
|---|---|
| Model | Human evidence review |
| Sample | Narrative synthesis of human studies |
| Intervention | Creatine monohydrate during immobilization, reloading and rehabilitation contexts |
| Duration | Varied by included study |
| Endpoints | Muscle cross-sectional area; Strength; Power; Functional recovery; Rehabilitation outcomes |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Citation network
Articles citing this research paper
Biohack Blueprint analyses that reference this study in their evidence base.
- Creatine for Muscle Growth: Lean Mass, Hypertrophy and Resistance Training EvidenceCreatine for muscle growth: what meta-analyses show about lean mass, strength, water weight, training volume and whether creatine builds muscle without lifting.Read analysis
- Creatine for Older Adults: Strength, Function, Muscle and Healthy AgingCreatine for older adults: what randomized trials and meta-analyses show about strength, muscle mass, physical function, cognition and practical dosing.Read analysis
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified
